CFO of Axsome Therapeutics Inc (30-Year Financial, Insider Trades) Nick Pizzie (insider trades) bought 777 shares of AXSM on 06/29/2020 at an average price of $76.64 a share. The total cost of this purchase was $59,549.
Axsome Therapeutics Inc is a pharmaceutical company in the United States. It focuses on developing novel therapeutics for the redressal of diseases related to the central nervous system. Axsome Therapeutics Inc has a market cap of $2.83 billion; its shares were traded at around $76.36 . GuruFocus has detected 1 severe warning sign with Axsome Therapeutics Inc. .
CFO Recent Trades:
- CFO Nick Pizzie bought 777 shares of AXSM stock on 06/29/2020 at the average price of $76.64. The price of the stock has decreased by 0.37% since.
Directors and Officers Recent Trades:
- Director Mark Coleman bought 650 shares of AXSM stock on 06/29/2020 at the average price of $78.5. The price of the stock has decreased by 2.73% since.
For the complete insider trading history of AXSM, click here
.